Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» oncology
oncology
Why is pharma going gaga for radiopharmaceuticals?
Pharmaphorum
Tue, 02/27/24 - 11:19 am
radiopharmaceuticals
oncology
Novartis
Eli Lilly
Bristol Myers Squibb
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Was Pfizer’s “Here’s to Science” commercial during the Super Bowl a winning play or a fumble?
Stat
Mon, 02/12/24 - 11:09 pm
Pfizer
pharma advertising
Super Bowl
oncology
cancer
Pfizer launches oncology ad campaign at Super Bowl LVIII
Medical Marketing and Media
Sun, 02/11/24 - 03:55 pm
Pfizer
oncology
Super Bowl
pharma advertising
Jazz buys KRAS inhibitors from Redx in $880m deal
Pharmaphorum
Wed, 02/7/24 - 11:18 am
Jazz Pharma
Redx Pharma
KRAS inhibitors
oncology
Gilead will not buy Tizona after paying $300M for the right to do so
Fierce Biotech
Wed, 02/7/24 - 11:17 am
Gilead Sciences
Tizona Therapeutics
M&A
oncology
Top 40 Best-Selling Oncology Drugs in 2023 by 2022 Data
Xtalks
Mon, 02/5/24 - 10:17 am
oncology
cancer
Keytruda
Revlimid
Opdivo
Imbruvica
Darzalex
Merck
Bristol Myers Squibb
AbbVie
Janssen
CG Oncology prices larger-than-expected $380M IPO in hopeful sign for biotech
BioPharma Dive
Wed, 01/24/24 - 11:36 pm
CG Oncology
IPOs
cancer
oncology
CG Oncology aims for $209M IPO, as more biotechs eye path to public markets
Fierce Biotech
Thu, 01/18/24 - 11:11 am
CG Oncology
IPOs
oncology
bladder cancer
Study finds hundreds of overlooked cancer drug targets
Pharmaphorum
Fri, 01/12/24 - 09:42 am
cancer
oncology
drug discovery
Wellcome Sanger Institute
JPM24: Even after Seagen buyout, Pfizer oncology chief still eyes ADC deals
Fierce Pharma
Thu, 01/11/24 - 11:34 am
Pfizer
oncology
cancer
antibody-drug conjugate
JPMHC 2024
FDA’s CAR T Probe ‘Not a Big Deal’ for Oncology-Focused Biotechs: Triumvira President
BioSpace
Wed, 01/10/24 - 06:25 pm
oncology
CAR-T
regulatory
FDA
BioNTech predicts return to revenue growth in 2025
Reuters
Tue, 01/9/24 - 09:44 am
BioNTech
oncology
Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink
BioSpace
Wed, 01/3/24 - 09:36 am
Roche
MediLink Therapeutics
oncology
antibody-drug conjugate
Oncology drugmakers seek the sweet spot between efficacy and tolerability
Pharma Voice
Mon, 12/11/23 - 10:16 am
cancer
oncology
drug development
FDA
FDA renews Syapse collaboration to use real-world data in oncology
Clinical Trials Arena
Wed, 12/6/23 - 08:53 pm
FDA
oncology
real world data
Syapse
‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs
Fierce Biotech
Tue, 12/5/23 - 09:46 am
BrainChild Bio
pediatric cancer
clinical trials
CAR-T
oncology
brain cancer
Gilead Oncology’s brand refresh takes back the possibilities cancer steals
Medical Marketing and Media
Mon, 11/20/23 - 09:36 pm
Gilead Oncology
branding
oncology
cancer
Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience
BioSpace
Wed, 11/15/23 - 11:58 am
Alkermes
spinoffs
oncology
Mural Oncology
NASDAQ
FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation
Fierce Pharma
Wed, 11/15/23 - 11:20 am
FDA
regulatory
oncology
cancer
accelerated approvals
Acrotech Biopharma
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »